Platelet CountNeutropeniaBlood PlateletsPlatelet AggregationThrombocytopeniaPlatelet AdhesivenessPlatelet TransfusionLeukocyte CountPlatelet Membrane GlycoproteinsBlood Cell CountThrombocytosisPlatelet Factor 4Purpura, Thrombocytopenic, IdiopathicPlatelet Function TestsAgranulocytosisMegakaryocytesFebrile NeutropeniaPlatelet Glycoprotein GPIIb-IIIa ComplexGranulocyte Colony-Stimulating FactorFeverPlatelet Glycoprotein GPIb-IX ComplexThrombopoietinBleeding TimePlatelet Activating FactorChemotherapy-Induced Febrile NeutropeniaAntineoplastic Combined Chemotherapy ProtocolsPurpura, ThrombocytopenicTreatment OutcomeDrug Administration ScheduleThrombinAntigens, Human PlateletFibrinogenSplenectomyThrombopoiesisAdenosine DiphosphateErythrocyte CountThrombosisTime FactorsCD4 Lymphocyte CountP-SelectinHemostasisInfusions, IntravenousBlood CoagulationDose-Response Relationship, DrugDisseminated Intravascular CoagulationNeutrophilsRetrospective Studiesvon Willebrand FactorNeoplasmsBone MarrowHematologic DiseasesRecombinant ProteinsLeukopeniaThrombocythemia, EssentialPaclitaxelHematologic TestsHemorrhageProspective StudiesTaxoidsHELLP SyndromeHematologyBlood Coagulation DisordersProthrombin TimeReceptors, ThrombopoietinPlatelet Membrane Glycoprotein IIbCell CountAntineoplastic AgentsHypersplenismHematopoiesisHematocritBlood Coagulation TestsSurvival AnalysisAspirinCamptothecinCyclophosphamideMaximum Tolerated DoseThromboxane A2Antibodies, MonoclonalPlateletpheresisPartial Thromboplastin TimeCisplatinSurvival RateDeoxycytidinePrognosisPlatelet Factor 3CollagenRisk FactorsAntineoplastic Agents, PhytogenicHeparinCarboplatinBlood Coagulation FactorsPregnancy Complications, HematologicFluorouracilLeukocyte ElastasePlatelet-Rich PlasmaPlatelet Storage Pool DeficiencySerotoninHematologic NeoplasmsThrombelastographyBlood Transfusion